Ross Chambers
Director
Antibody Discovery
Integral Molecular
United States of America
Biography
Ross Chambers directs all antibody discovery projects at Integral Molecular. He brings over a decade of experience in industry leading the discovery of more than 2,000 antibodies. Dr. Chambers pioneered the use of DNA immunization for the production of antibodies in 2003, commercialized Genomic Antibody Technology (GAT) for the rapid isolation of antibodies, and developed the Picodroplet cloning system for the isolation of antibodies directly from B cells. Dr. Chambers was previously the Director of Research and Development at SDIX, where he directed the discovery of thousands of commercial antibodies using DNA immunization, B cell cloning, and other isolation techniques. Before that he developed DNA immunization for large-scale antibody isolation projects at UT Southwestern. Dr. Chambers earned his Ph.D. from the University of Otago, New Zealand, and completed post-docs at UC Davis and Berkeley.
Research Interest
commercial antibodies using DNA immunization, B cell cloning,
